EDP Sciences logo
Soumettre un article
rechercher
Menu
Accueil Tous les numéros Volume 21 / Numéro 3 (May-June 2014) OCL, 21 3 (2014) D308 Références
Open Access
Numéro
OCL
Volume 21, Numéro 3, May-June 2014
Numéro d'article D308
Nombre de pages 6
Section Dossier: Vitamin D, vitamin or hormone? / La vitamine D, vitamine ou hormone ?
DOI https://doi.org/10.1051/ocl/2013055
Publié en ligne 29 avril 2014
  • Anderson JL, May HT, Horne BD, et al. 2010. Intermountain Heart Collaborative (IHC) Study Group. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 106: 963–968. [CrossRef] [PubMed] [Google Scholar]
  • Autier P, Gandini S. 2007. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 167: 1730–1707 [Google Scholar]
  • Avenell A, Gillespie WJ, Gillespie LD, O’Connell D. 2009. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst. Rev. 15: CD000227. [Google Scholar]
  • Bjelakovic G, Gluud LL, Nikolova D, et al. 2011. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst. Rev. 6: CD007470. [Google Scholar]
  • Bland R, Markovic D, Hills CE, et al. 2004. Expression of 25-hydroxyvitamin D3–1alpha-hydroxylase in pancreatic islets. J. Steroid. Biochem. Mol. Biol. 89-90: 121–125. [CrossRef] [PubMed] [Google Scholar]
  • Bolland MJ, Barber PA, Doughty RN, et al. 2008. Vascular events in healthy older women receiving calcium supplementation randomised controlled trial. BMJ 336: 262–266. [Google Scholar]
  • Chapuy MC, Arlot ME, Duboeuf F, et al. 1992. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N. Engl. J. Med. 327: 1637–1642. [Google Scholar]
  • Chen S, Glenn DJ, Ni W, et al. 2008. Expression of the vitamin d receptor is increased in the hypertrophic heart. Hypertension 52: 1106–1112 [Google Scholar]
  • Cormier C, Courbebaisse M, Maury E, Thervet E, Souberbielle JC. 2010. Effect of vitamin D deficiency on cardiovascular risk. J. Mal. Vasc. 35: 235–241. [CrossRef] [PubMed] [Google Scholar]
  • Davidson MB, Duran P, Lee ML, Friedman TC. 2013. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 36: 260–266. [CrossRef] [PubMed] [Google Scholar]
  • Doorenbos CR, van den Born J, Navis G, de Borst MH. 2009. Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nat. Rev. Nephrol. 5: 691–700 [CrossRef] [PubMed] [Google Scholar]
  • Draznin B, Sussman K, Kao M, Lewis D, Sherman N. 1987. The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J. Biol. Chem. 262: 14385–14388. [PubMed] [Google Scholar]
  • Dror Y, Giveon SM, Hoshen M, Feldhamer I, Balicer RD, Feldman BS. Vitamin D levels for preventing acute coronary syndrome and mortality: evidence of a nonlinear association. J. Clin. Endocrinol. Metab. 98: 2160–2167 [Google Scholar]
  • Dunlop TW, Väisänen S, Frank C, Molnár F, Sinkkonen L, Carlberg C. 2005. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1α,25-dihydroxyvitamin D3 and its nuclear receptor. J. Mol. Biol. 349: 248–260. [CrossRef] [PubMed] [Google Scholar]
  • Durup D, Jorgensen HL, Christensen J, Schwarz P, Heegaard AM, Lind B. 2012. A reverse J-shaped association of all cause mortality with serum 25-hydroxyvitaminD in general practice: the CopD Study. J. Clin. Endocrinol. Metab. 97: 2644–2652 [CrossRef] [PubMed] [Google Scholar]
  • Elamin MB, Abu Elnour NO, Elamin KB, et al. 2011. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96: 1931–1942 [CrossRef] [PubMed] [Google Scholar]
  • George PS, Pearson ER, Witham MD. 2012. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med. 29: 142–150. [CrossRef] [Google Scholar]
  • Holick M, Binkley N, Bischoff-Ferrari H, et al. 2011. Endocrine Society. Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96: 1911–1930. [Google Scholar]
  • Hypponen E, Power C. 2006. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: The role of obesity. Diabetes Care 29: 2244–2246. [CrossRef] [PubMed] [Google Scholar]
  • Johnson JA, Grande JP, Roche PC, Kumar R. 1994. Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am. J. Physiol. 267: E356–360. [PubMed] [Google Scholar]
  • Karakas M, Thorand B, Zierer A, et al. 2013. Low levels of serum 25-hydroxyvitamin D are associated with increased risk of myocardial infarction, especially in women: results from the MONICA/KORA Augsburg case-cohort study. J. Clin. Endocrinol. Metab. 98: 272–280. [CrossRef] [PubMed] [Google Scholar]
  • Kestenbaum B, Katz R, de Boer I, et al. 2011. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J. Am. Coll. Cardiol. 58: 1433–1441. [CrossRef] [PubMed] [Google Scholar]
  • Krause R, Buhring M, Hopfenmuller W, Holick M, Sharma AM. 1998. Ultraviolet B and blood pressure. Lancet 352: 709–710. [CrossRef] [Google Scholar]
  • Kunutsor SK, Apekey TA, Steur M. 2013. Vitamin D and risk of future hypertension: meta-analysis of 283 537 participants. Eur. J. Epidemiol. DOI: 10.1007/s10654-013-9874. [Google Scholar]
  • Larsen T, Mose FH, Bech JN, Hansen A.B, Pedersen EB. 2012. Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am. J. Hypertens. 25: 1215–1222. [CrossRef] [PubMed] [Google Scholar]
  • Lee P, Greenfield JR, Campbell LV. 2009. Vitamin D insufficiency–a novel mechanism of statin-induced myalgia? Clin. Endocrinol. 71: 154–155. [CrossRef] [Google Scholar]
  • London G, Guerin A, Verbeke F, et al. 2007. Mineral metabolism and arterial functions in end-stage renal disease:potential role of 25-hydroxyvitamin D deficiency. J. Am. Soc. Nephrol. 18: 613–662. [CrossRef] [PubMed] [Google Scholar]
  • Maestro B, Dávila N, Carranza MC, Calle C. 2003. Identification of a Vitamin D response element in the human insulin receptor gene promoter. J. Steroid. Biochem. Mol. Biol. 84: 223–230. [CrossRef] [PubMed] [Google Scholar]
  • Maestro B, Molero S, Bajo S, Dávila N, Calle C. 2002. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). Cell Biochem. Funct. 20: 227–232. [CrossRef] [PubMed] [Google Scholar]
  • Maestro B, Campión J, Dávila N, Calle C. 2000. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr. J. 47: 383–391. [CrossRef] [PubMed] [Google Scholar]
  • Manson JE, Bassuk SS, Lee JM, et al. 2012. The vitamin D and Omega A-3 Trial (Vital) nationale and design of a charge randomized controlled trial of vitamin D and marine omega 3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp. Clin. Trials 33 : 159–171 [CrossRef] [PubMed] [Google Scholar]
  • Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. 2011. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am. J. Clin. Nutr. 94: 486–494. [Google Scholar]
  • Pfeifer M, Begerow B, Minne H, Nachtigall D, Hansen C. 2001. Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J. Clin. Endocrinol. Metab. 86: 1633–1637 [PubMed] [Google Scholar]
  • Pilz S, Tomaschitz A, März W, Drechsler C, Ritz E, Zittermann A. 2011. Vitamin D, cardiovascular disease and mortality. Clin. Endocrinol. 75: 575–584. [CrossRef] [Google Scholar]
  • Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S. 2011. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am. J. Kidney Dis. 58: 374–382. [Google Scholar]
  • Pilz S, Tomaschitz A, Drechsler C, Dekker JM, März W. Vitamin D deficiency and myocardial diseases. Mol. Nutr. Food Res. 54: 1103–1113. [PubMed] [Google Scholar]
  • Pittas AG, Lau J, Hu FB, Dawson-Hughes B. 2007. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 92: 2017–2029. [CrossRef] [PubMed] [Google Scholar]
  • Pittas AG, Dawson-Hughes B, Li T, et al. 2006. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29: 650–656. [CrossRef] [PubMed] [Google Scholar]
  • Pittas AG, Chung M, Trikalinos T, et al. 2000. Systematic review: vitaminD and cardiometabolic outcomes. An. Intern. Med. 152: 307–314 [CrossRef] [Google Scholar]
  • Souberbielle JC, Courbebaisse M, Cormier C, et al. 2012. When should we measure vitamin D concentration in clinical practice? Scand J. Clin. Lab. Invest. 243: 129–135. [PubMed] [Google Scholar]
  • Tarcin O, Yavuz DG, Ozben B, et al. 2009. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J. Clin. Endocrinol. Metab. 4023–4030. [Google Scholar]
  • Trummer O, Pilz S, Hoffmann MM, et al. 2013. Vitamin D and Mortality: A Mendelian Randomization Study. Clin. Chem. 59: 793–797. [CrossRef] [PubMed] [Google Scholar]
  • Wang L, Song Y, Manson JE, et al. 2012. Circulating 25-hydroxy-vitamin d and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes. 5: 819–829. [CrossRef] [PubMed] [Google Scholar]
  • Wang L, Manson JE, Song Y, Sesso HD. 2010. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann. Intern. Med. 152: 315–323 [CrossRef] [PubMed] [Google Scholar]
  • Witham MD, Nadir MA, Struthers AD. 2009. Effect of vitamin D on blood pressure’ a systematic review and meta-analysis. J. hypertens. 27: 1948–1954. [Google Scholar]
  • Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. 2003. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J. 17: 509–511. [PubMed] [Google Scholar]
  • Zittermann A, Kuhn J, Dreier J, Knabbe C, Gummert JF, Borgermann J. 2013. Vitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiac surgery. Eur. Heart J. 34: 1358–1364 [CrossRef] [PubMed] [Google Scholar]
  • Zitterman A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S, 2012. Vitamin D deficiency and mortality risk in general population: a meta analysis of prospective cohort studies. Am. J. Clin. Nutr. 95: 91–100. [Google Scholar]
  • Zittermann A, Schleithoff S, Koerfer R. 2007. Vitamin D and vascular calcification. Curr. Opin. Lipidol. 18: 41–46. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.